Literature DB >> 9784099

Design of benzamidine-type inhibitors of factor Xa.

B Gabriel1, M T Stubbs, A Bergner, J Hauptmann, W Bode, J Stürzebecher, L Moroder.   

Abstract

A series of derivatives of rac-benzenesulfonyl-glycyl-phenylalanine or its ethyl ester with a combination of thioamido/amidino or amidino/amidino substituents in the benzene rings was synthesized as potential inhibitors of factor Xa (fXa). Among these, the racemic 4'-amidinobenzenesulfonyl-glycyl-4-amidinophenylalanine ethyl ester was found to exhibit the highest affinity for fXa despite the unfavored location of the amidino substituent in the para position. X-ray structural analysis of the trypsin complex with this bis-benzamidine compound revealed a retro-binding mode if compared to those of similar compounds, so far analyzed in complexes with trypsin or fXa. This noncanonical binding mode as well as its slow plasma clearance rates in rats, if compared to those of other benzamidine derivatives, suggests this compound as an interesting new lead structure for the design of fXa inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784099     DOI: 10.1021/jm980227t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

Authors:  S Sperl; U Jacob; N Arroyo de Prada; J Stürzebecher; O G Wilhelm; W Bode; V Magdolen; R Huber; L Moroder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Influence of structural variations in peptidomimetic 4-amidinophenylalanine-derived thrombin inhibitors on plasma clearance and biliary excretion in rats.

Authors:  Jörg Hauptmann; Torsten Steinmetzer; Helmut Vieweg; Peter Wikström; Jürg Stürzebecher
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

3.  Green by Design: Convergent Synthesis, Computational Analyses, and Activity Evaluation of New FXa Inhibitors Bearing Peptide Triazole Linking Units.

Authors:  Diego F Rodríguez; Francisca Durán-Osorio; Yorley Duarte; Pedro Olivares; Yanina Moglie; Kamal Dua; Flavia C Zacconi
Journal:  Pharmaceutics       Date:  2021-12-24       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.